<DOC>
	<DOC>NCT00923260</DOC>
	<brief_summary>The aim of the present study was to evaluate the additional effect of sudden visceral fat reduction by omentectomy on Metabolic Syndrome, acute phase reactants and inflammatory mediators in patients with morbid obesity undergoing Laparoscopic Roux-en-Y Gastric Bypass.</brief_summary>
	<brief_title>Omentectomy and Metabolic Syndrome</brief_title>
	<detailed_description>Although weight loss controls Metabolic Syndrome and reduces the level of inflammatory markers in patients with Morbid Obesity, patients may enjoy the benefit achieving metabolic control before significant weight loss occurs.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Obesity, Morbid</mesh_term>
	<criteria>BMI &gt; 35 Kg/m2 Metabolic syndrome diagnosed Type 1 diabetes Uncontrolled type 2 diabetes Cirrhosis or active hepatitis Pregnancy Recent MI or stroke</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Omentectomy</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>acute phase reactants</keyword>
</DOC>